CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

CRISPR Therapeutics (NasdaqGM:CRSP) recently announced the departure of Chief Operating Officer Julianne Bruno, reflecting a notable leadership change that could influence its operational direction.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

Science is discovery and discovery evolve. Few discoveries have elicited as much excitement in the scientific world in recent times ...

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a report released on ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

With the citrus industry at a crossroads, growers are looking for any solution to cope with the deadly citrus greening ...

Crispr Therapeutics said Chief Operating Officer Julianne Bruno would depart the company to pursue other opportunities, effective April 11. Bruno joined the gene-editing company in 2019 and stepped ...

Decades ago, Amber Salzman remembers feeling like there was nothing she could do to help her cousin-in-law with a progressive ...

In a medical first, a research team in China has successfully stitched a CRISPR gene-edited pig liver into a brain-dead ...